MondayMar 18, 2024 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Huge 2024 Milestone with FDA Clearance for its Planned U.S. Phase 1b Hypertension Clinical Trial

Lexaria, a global innovator in drug delivery platforms, recently received FDA clearance for its HYPER-H23-1 clinical study John Docherty, President of Lexaria, has regarded this milestone as a demonstration of its patented DehydraTECH(TM) technology’s overall viability, particularly in the potential treatment of hypertension With HYPER-H23-1, Lexaria looks to build on the success of its previous human clinical studies, whose results have been overwhelmingly positive This marks a considerable milestone even as the company looks to double down on GLP-1 studies for the 2024 calendar year Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced that the…

Continue Reading

FridayMar 15, 2024 4:20 pm

420 with CNW — Missouri Announces Date for Submission of Additional Cannabis Microbusiness Applications

The Missouri Department of Health and Senior Services (DHSS) is set to begin receiving the next wave of applications for microbusiness licenses electronically, using its online registry platform. The application window is slated to open from April 15 to April 29, 2024, with licensing expected to be finalized by July. Last year, the department granted 48 licenses for microbusiness establishments, marking the conclusion of the initial phase in a series of three rounds for the allocation of such licenses. Microbusinesses refer to licenses for cannabis facilities exclusively available to qualifying individuals and entities and are aimed at facilitating the involvement…

Continue Reading

FridayMar 15, 2024 10:00 am

Reports Suggest DEA Resisting Pressure from White House to Reclassify Marijuana

According to a recently published article, some Drug Enforcement Administration officials may be resisting calls to move cannabis to a lower schedule. This has created tension with the White House, especially as the president continues to laud his role in spearheading the marijuana review. Certain officials appear to be contesting scientific findings from the U.S. Health and Human Services, which were the basis of the department’s recommendation that cannabis be resclassified under the Controlled Substances Act. The article highlights that the officials are concerned about issues linked to THC potency and are still not convinced by the conclusion made by…

Continue Reading

ThursdayMar 14, 2024 7:47 pm

Tether Engages Budtenders Across Canada for its Annual Budtender Appreciation Week

Canadian Budtender community gears up for sampling events in Vancouver, Oakville, and Edmonton through March 24-31, 2024 Toronto, March 14, 2024 -- Toronto, ON, March 14, 2024 - Tether, a leading name in the Canadian cannabis industry, is preparing for a week’s worth of events in honour of the third annual Budtender Appreciation Week (“B-Week”), an initiative created to recognize and celebrate the contributions of cannabis retail workers across Canada. This year's events promise to be bigger than ever, featuring sampling events in Vancouver, BC, Oakville, ON, and Edmonton, AB through March 24-31, 2024. As part of Tether's commitment to…

Continue Reading

ThursdayMar 14, 2024 4:20 pm

420 with CNW — Research Finds 7 in 10 Americans Live in States with Legal Cannabis

Despite federal prohibition, cannabis has gained legal status across many of the states in the United States, whether for recreational or medical use. According to recent research from the Pew Research Center, a majority of Americans, approximately 74%, now reside in states where cannabis is permissible in some form. Among these, about 54% live in states where recreational use is allowed. Currently, a significant portion of states — 24, along with the District of Columbia — have given the green light to recreational cannabis. Furthermore, 14 states have legalized cannabis solely for medical applications, while the rest, totaling 12 states,…

Continue Reading

WednesdayMar 13, 2024 4:20 pm

420 with CNW — Analysis of Differences Between Taxes on Marijuana, Sports Betting

In 2021, Arizona witnessed the legalization of two long-operating but previously illicit industries: sports betting and recreational cannabis. This change brought a surge of tax revenue to the state, with one industry outpacing the other significantly. While sports betting enjoys greater popularity per capita in the state, it contributes only a small percentage of the taxes compared to the marijuana sector. According to 2023 revenue data, the total wagering amount on sportsbooks in the state was almost five times greater than the state’s entire marijuana sales. However, despite this, the tax revenue from cannabis companies was more than eight times…

Continue Reading

WednesdayMar 13, 2024 11:00 am

How Illinois’ Adult-Use Cannabis Prices Compare Regionally

In 2023, the state of Illinois raked in billions in recreational cannabis sales. This is despite the fact that prices in the state are among the highest in the country. In total, Illinois raked in more than $1.5 billion in sales, with more than 42 million products being sold at dispensaries throughout the state. This brought in about $400 million in recreational cannabis tax revenue. Tax revenue from sales is allocated to a number of departments in the state, among them substance abuse, criminal justice prevention programs and public health. Illinois also reported that marijuana sales to residents hit a…

Continue Reading

TuesdayMar 12, 2024 4:20 pm

420 with CNW — 2023 Marijuana Business Licenses Declined in US, Data Firm Says

The number of active cannabis company licenses in the United States saw a substantial dip in 2023, the first decline following years of steady increase, according to a recent CRB Monitor report. According to the data, there was a 4% drop in the number of active marijuana licenses in the U.S. between 2022 and 2023. On the other hand, Canada saw a 2% growth in the quantity of active marijuana business permits over the same period. CRB Monitor is a company based in Nashville, Tennessee, specializing in marijuana intelligence and license monitoring. Since 2019, the combined total of active licenses…

Continue Reading

MondayMar 11, 2024 4:20 pm

420 with CNW — Study Shows Cannabis Users Less Likely to Suffer Cognitive Decline

A recent study suggests a potential link between cannabis use and reduced instances of subjective cognitive decline (SDC), wherein individuals who incorporate cannabis into their routines, whether for medical or recreational purposes, report experiencing less memory impairment and confusion than nonusers. Published in the “Current Alzheimer Research” Journal, the study’s significance lies in its departure from prior research that has often associated subjective cognitive decline with a higher risk of dementia in later life. The findings challenge conventional assumptions about the cognitive impacts of THC, the primary psychoactive component of marijuana. The research, conducted by scholars from SUNY Upstate Medical…

Continue Reading

MondayMar 11, 2024 11:15 am

New Research Challenges Stereotype That Cannabis Users Are Couch Potatoes

New research has challenged the stereotype that cannabis users are lazy and inactive. The research was conducted by investigators at The Ohio University and the University of Texas at Dallas and involved more than 2,500 adults who took part in the National Longitudinal Study of Adolescent to Adult Health in the period between 2016 to 2018. This research is the first to examine the link between the use of e-cigarettes, cannabis and physical activity. The investigators found that the use of e-cigarettes and cannabis among participants forecasted their penchant for exercises such as walking, with cannabis users walking more times…

Continue Reading

Official NewsWire Relationships

Alternative Products Expo Benzinga Cannabis Capital Conference Cannabis Business Summit & Expo 2019 Cannabis Drinks Expo Cannabis World Congress & Business Exposition Cannexpo Marigold PR MjMicro Conference New England Cannabis Network O'Cannabiz Conference & Expo Tether BudTender Tether BudTender Appreciation Week

CannabisNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000